Old Web
English
Sign In
Acemap
>
authorDetail
>
K.A. Lytkina
K.A. Lytkina
Medicine
in patient
genetically engineered
Rheumatoid arthritis
Clinical Practice
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative efficacy of genetically engineered biological drugs in real clinical practice according to the Moscow Unified Arthritis Registry (MUAR) data
2021
E.A. Rosochkina
G. V. Lukina
E.N. Koltsova
K.A. Lytkina
E. I. Shmidt
A. I. Zagrebneva
E. V. Zhilyaev
Show All
Source
Cite
Save
Citations (0)
Levilimab in patients with COVID-19 in real-life practice
2021
E. V. Tavlueva
I. G. Ivanov
K.A. Lytkina
P.A. Plesovskiy
T.V. Bezuglaya
S. R. Fridman
T. A. Meleshkevich
V. V. Strizheletskiy
G G Melkonyan
G.Yu. Melik-Ogandzhanyan
M. A. Uyanaeva
E.A. Bezuglaya
D. N. Khobotnikov
P.S. Pukhtinskaia
V.V. Mladov
Show All
Source
Cite
Save
Citations (0)
Targeted anti-inflammatory therapy effect on various indicators of the psoriatic arthritis activity: Moscow Unified Arthritis Registry (MUAR) data
2021
K.A. Lytkina
G. V. Lukina
E.N. Koltsova
E. I. Shmidt
E. V. Zhilyaev
Show All
Source
Cite
Save
Citations (0)
Clinical significance of the direct analgesic effect of targeted medications in patients with rheumatoid arthritis
2020
E. V. Zhilyaev
AO Emc, Moscow, Russian Federation
G. V. Lukina
E.N. Koltsova
E. I. Shmidt
K.A. Lytkina
Show All
Source
Cite
Save
Citations (1)
Experience of using a genetically engineered biological drug biosimilar in patients with rheumatoid arthritis in real clinical practice
2020
E. V. Zhilyaev
E.N. Koltsova
E. I. Shmidt
K.A. Lytkina
G. V. Lukina
Show All
Source
Cite
Save
Citations (0)
1